Research News

---

Topic: Chemotherapy (view all topics)

Tags for topic Chemotherapy:

• Abraxane (chemical name: paclitaxel)
• Adjuvant
• Adriamycin (chemical name: doxorubicin)
• Anthracyclines
• carboplatin (brand name: Paraplatin)
• Cytoxan (chemical name: cyclophosphamide)
• daunorubicin (brand names: Cerubidine, DaunoXome)
• Dose Dense
• Doxil (chemical name: doxorubicin)
• Ellence (chemical name: epirubicin)
• fluorouracil (also called 5-fluorouracil or 5-FU; brand name: Adrucil)
• Halaven (chemical name: eribulin)
• Ixempra (chemical name: ixabepilone)
• mitoxantrone (brand name: Novantrone)
• Navelbine (chemical name: vinorelbine)
• Neoadjuvant
• Standard
• Taxanes
• Taxol (chemical name: paclitaxel)
• Taxotere (chemical name: docetaxel)
• Xeloda (chemical name: capecitabine)

View articles by month and year

• MRI Better at Assessing Results of Chemo Before Surgery

  Published on June 5, 2012 at 12:00 am

  • Tags: Breast MRI and Neoadjuvant

  Research shows that breast MRI before surgery is better at assessing how well a cancer responds to neoadjuvant treatment compared to more traditional assessment measures such as a physical exam, mammogram, or ultrasound.

• Afinitor Before Surgery Doesn’t Help Treat HER2-Negative Breast Cancer

  Published on December 11, 2011 at 12:00 am

  • Tags: Abraxane (chemical name: paclitaxel), Cytoxan (chemical name: cyclophosphamide), Ellence (chemical name: epirubicin), Taxol (chemical name: paclitaxel), Standard, Neoadjuvant, Afinitor, Avastin, and Neoadjuvant

  Research has found that adding Afinitor to paclitaxel didn't improve the response to neoadjuvant treatment with paclitaxel in women diagnosed with advanced-stage, HER2-negative breast cancer.

• Experimental Genomic Test May Help Determine Need for Chemo Before Surgery

  Published on May 11, 2011 at 12:00 am

  • Tags: Standard and Neoadjuvant

  An experimental genomic test may help doctors figure out if invasive HER2-negative breast cancer will respond to chemotherapy before surgery.